These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28076423)

  • 41. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.
    Simard J; Dumont M; Moisan AM; Gaborieau V; Malouin H; Durocher F; Chiquette J; Plante M; Avard D; Bessette P; Brousseau C; Dorval M; Godard B; Houde L; ; Joly Y; Lajoie MA; Leblanc G; Lépine J; Lespérance B; Vézina H; Parboosingh J; Pichette R; Provencher L; Rhéaume J; Sinnett D; Samson C; Simard JC; Tranchant M; Voyer P; Easton D; Tavtigian SV; Knoppers BM; Laframboise R; Bridge P; Goldgar D
    J Med Genet; 2007 Feb; 44(2):107-21. PubMed ID: 16905680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
    Ellingson MS; Hart SN; Kalari KR; Suman V; Schahl KA; Dockter TJ; Felten SJ; Sinnwell JP; Thompson KJ; Tang X; Vedell PT; Barman P; Sicotte H; Eckel-Passow JE; Northfelt DW; Gray RJ; McLaughlin SA; Moreno-Aspitia A; Ingle JN; Moyer AM; Visscher DW; Jones K; Conners A; McDonough M; Wieben ED; Wang L; Weinshilboum R; Boughey JC; Goetz MP
    Breast Cancer Res Treat; 2015 Sep; 153(2):435-43. PubMed ID: 26296701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of BRCA1 and BRCA2 variants in multi-ethnic Asian cohort from a Malaysian case-control study.
    Lai KN; Ho WK; Kang IN; Kang PC; Phuah SY; Mariapun S; Yip CH; Mohd Taib NA; Teo SH
    BMC Cancer; 2017 Feb; 17(1):149. PubMed ID: 28222693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
    Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
    Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
    Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
    Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.
    Duffy DL; Antill YC; Stewart CJ; Young JP; ; Spurdle AB
    Twin Res Hum Genet; 2011 Apr; 14(2):111-8. PubMed ID: 21425892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
    Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
    Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.
    Zhi X; Szabo C; Chopin S; Suter N; Wang QS; Ostrander EA; Sinilnikova OM; Lenoir GM; Goldgar D; Shi YR
    Hum Mutat; 2002 Dec; 20(6):474. PubMed ID: 12442274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families.
    Nielsen HR; Petersen J; Krogh L; Nilbert M; Skytte AB
    Fam Cancer; 2016 Oct; 15(4):523-8. PubMed ID: 26951453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.
    Li J; Li H; Makunin I; ; Thompson BA; Tao K; Young EL; Lopez J; Camp NJ; Tavtigian SV; John EM; Andrulis IL; Khanna KK; Goldgar D; Chenevix-Trench G
    Breast Cancer Res Treat; 2017 Dec; 166(3):937-949. PubMed ID: 28840378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Germline Variants of Prostate Cancer in Japanese Families.
    Hayano T; Matsui H; Nakaoka H; Ohtake N; Hosomichi K; Suzuki K; Inoue I
    PLoS One; 2016; 11(10):e0164233. PubMed ID: 27701467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
    Maguire P; Holmberg K; Kost-Alimova M; Imreh S; Skoog L; Lindblom A
    Int J Mol Med; 2005 Jul; 16(1):135-41. PubMed ID: 15942690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers.
    Joris S; Giron P; Olsen C; Seneca S; Gheldof A; Staessens S; Shahi RB; De Brakeleer S; Teugels E; De Grève J; Hes FJ
    BMC Cancer; 2024 Jun; 24(1):723. PubMed ID: 38872153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.
    van der Merwe N; Peeters AV; Pienaar FM; Bezuidenhout J; van Rensburg SJ; Kotze MJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RECQL: a new breast cancer susceptibility gene.
    Banerjee T; Brosh RM
    Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
    Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
    Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics and genetic analysis of a case of a patient with familial hereditary breast cancer: a case report.
    Liu Y; Mao J; Xiang L; Zhang X; Qu Z
    J Med Case Rep; 2024 Aug; 18(1):368. PubMed ID: 39138583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.